J&J Has An Appetite For Pharma M&A, But Knows What It Likes

 
• By Jessica Merrill

CEO Joaquin Duato said J&J is agnostic on size when it comes to business development but has generally found more value creation in earlier-stage deals.

Plate
J&J is hungry for deals, but not necessarily big ones. • Source: Shutterstock

More from Earnings

More from Business